{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,1,31]],"date-time":"2024-01-31T00:43:09Z","timestamp":1706661789257},"reference-count":7,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T00:00:00Z","timestamp":1706572800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T00:00:00Z","timestamp":1706572800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006390","name":"University of Lausanne","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006390","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Retinoblastoma (rb) is the most frequent intraocular tumor, accounting for 3% of all childhood cancers. Heritable rb survivors are germline carriers for an RB1 mutation and have a lifelong risk to develop non-ocular second primary tumors (SPTs) involving multiple other organs like the bones, soft tissues, or skin. These SPTs usually become manifest several years succeeding the diagnosis of rb. In our instance, however, a non-ocular SPT presented prior to the diagnosis of heritable rb.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>We report a rare case of a monozygotic twin who presented with primary rhabdomyosarcoma (RMS) preceding the manifestation of heritable rb. The rb was diagnosed when the child developed strabismus while already on therapy for the RMS. The child underwent therapy for both as per defined treatment protocols. The rb regressed well on treatment, but the RMS relapsed and the child developed multiple refractory metastatic foci and succumbed to his disease.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Non-ocular SPTs like sarcomas are usually known to manifest in heritable rb survivors with a lag of two to three decades (earlier if exposure to radiation is present) from the presentation of the rb. However, in our case, this seemed to be reversed with the RMS being manifest at an unusual early age and the rb being diagnosed at a later point in time.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12886-024-03307-x","type":"journal-article","created":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T08:03:00Z","timestamp":1706601780000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["When the second comes first\u2013 rhabdomyosarcoma preceding heritable retinoblastoma\u2013 a case report"],"prefix":"10.1186","volume":"24","author":[{"given":"Devjyoti","family":"Tripathy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre","family":"Moulin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacques","family":"Bijon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carole","family":"Gengler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maja","family":"Beck-Popovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francis L.","family":"Munier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Stathopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,1,30]]},"reference":[{"issue":"7","key":"3307_CR1","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1001\/archophthalmol.2010.126","volume":"128","author":"KI Woo","year":"2010","unstructured":"Woo KI, Harbour JW. Review of 676 second primary tumors in patients with retinoblastoma: association between age at onset and tumor type. Arch Ophthalmol. 2010;128(7):865\u201370. https:\/\/doi.org\/10.1001\/archophthalmol.2010.126.","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"3307_CR2","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1002\/pbc.26193","volume":"64","author":"P Temming","year":"2017","unstructured":"Temming P, Arendt M, Viehmann A, et al. Incidence of second cancers after radiotherapy and systemic chemotherapy in heritable retinoblastoma survivors: a report from the German reference center. Pediatr Blood Cancer. 2017;64(1):71\u201380. https:\/\/doi.org\/10.1002\/pbc.26193.","journal-title":"Pediatr Blood Cancer"},{"key":"3307_CR3","doi-asserted-by":"publisher","first-page":"15021","DOI":"10.1038\/nrdp.2015.21","volume":"1","author":"H Dimaras","year":"2015","unstructured":"Dimaras H, Corson TW, Cobrinik D, et al. Retinoblastoma. Nat Rev Dis Primers. 2015;1:15021. https:\/\/doi.org\/10.1038\/nrdp.2015.21.","journal-title":"Nat Rev Dis Primers"},{"issue":"10","key":"3307_CR4","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1016\/S1470-2045(14)70336-5","volume":"15","author":"MC de Jong","year":"2014","unstructured":"de Jong MC, Kors WA, de Graaf P, et al. Trilateral retinoblastoma: a systematic review and meta-analysis. Lancet Oncol. 2014;15(10):1157\u201367. https:\/\/doi.org\/10.1016\/S1470-2045(14)70336-5.","journal-title":"Lancet Oncol"},{"key":"3307_CR5","doi-asserted-by":"publisher","unstructured":"Moll AC, Imhof SM, Bouter LM, et al. Second primary tumors in patients with hereditary retinoblastoma: a register-based follow-up study, 1945\u20131994. Int J Cancer. 1996;67(4):515\u20139. https:\/\/doi.org\/10.1002\/(SICI)1097-0215(19960807)67:4%3C515::AID-IJC9%3E3.0.CO;2-V.","DOI":"10.1002\/(SICI)1097-0215(19960807)67:4%3C515::AID-IJC9%3E3.0.CO;2-V"},{"issue":"1","key":"3307_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41572-018-0051-2","volume":"5","author":"SX Skapek","year":"2019","unstructured":"Skapek SX, Ferrari A, Gupta AA, et al. Rhabdomyosarcoma. Nat Rev Dis Primers. 2019;5(1):1. https:\/\/doi.org\/10.1038\/s41572-018-0051-2. [published Online First: 2019\/01\/09].","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"3307_CR7","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1111\/his.14449","volume":"80","author":"NP Agaram","year":"2022","unstructured":"Agaram NP. Evolving classification of rhabdomyosarcoma. Histopathology. 2022;80(1):98\u2013108. https:\/\/doi.org\/10.1111\/his.14449. PMID: 34958505; PMCID: PMC9425116.","journal-title":"Histopathology"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-024-03307-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-024-03307-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-024-03307-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T08:04:08Z","timestamp":1706601848000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-024-03307-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,30]]},"references-count":7,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3307"],"URL":"https:\/\/doi.org\/10.1186\/s12886-024-03307-x","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,30]]},"assertion":[{"value":"22 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Waived for single retrospective case reports.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The informed consent for publication is obtained from the parents of the deceased child.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"47"}}